LAUSR

Glioma Vaccine Shows Early Signs of Success.

Sign Up to like & get
recommendations!
1 Published in 2021 at "Cancer discovery"

DOI: 10.1158/2159-8290.cd-nb2021-0342

Abstract: A vaccine targeting IDH1 in patients with newly diagnosed diffuse glioma may be worth pursuing, researchers say. In a phase I trial, the vaccine was deemed safe, and it induced an immune response-including clonal expansion… read more here.

Keywords: early signs; vaccine shows; glioma; shows early ... See more keywords